The impact of pretransplant hepatic encephalopathy on survival following liver transplantation

Liver Transplantation

Volumn 21, Issue 7, 2015, Pages 873-880

  Wong, Robert J ^a   Aguilar, Maria ^a   Gish, Robert G ^b,c   Cheung, Ramsey ^c,d   Ahmed, Aijaz ^c  

^a HIGHLAND HOSPITAL   (United States)

^b HEPATITIS B FOUNDATION   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; DISEASE SEVERITY; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; KAPLAN MEIER METHOD; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; MORTALITY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SURVIVAL; UNITED STATES; AGED; COMPLICATION; END STAGE LIVER DISEASE; INTERNATIONAL NORMALIZED RATIO; MIDDLE AGED; MULTIVARIATE ANALYSIS; REGISTER; RISK FACTOR; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

BIOLOGICAL MARKER;

ADULT; AGED; BIOMARKERS; END STAGE LIVER DISEASE; FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; INTERNATIONAL NORMALIZED RATIO; KAPLAN-MEIER ESTIMATE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; UNITED STATES;

EID: 84933498830     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.24153     Document Type: Article

References (28)

1. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al.,; for United Network for Organ Sharing Liver Disease Severity Score Committee. Model for End-Stage Liver Disease (MELD) and allocation of donor livers. Gastroenterology 2003; 124: 91-96.
2. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al., A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464-470.
3. Wong RJ, Gish RG, Ahmed A,. Hepatic encephalopathy is associated with significantly increased mortality among patients awaiting liver transplantation. Liver Transpl 2014; 20: 1454-1461.
4. Cash WJ, McConville P, McDermott E, McCormick PA, Callender ME, McDougall NI,. Current concepts in the assessment and treatment of hepatic encephalopathy. QJM 2010; 103: 9-16.
5. Ham J, Gish RG, Mullen K,. Model for End-Stage Liver Disease (MELD) exception for hepatic encephalopathy. Liver Transpl 2006; 12 (suppl 3): S102-S104.
6. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT,. Hepatic encephalopathy - definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002; 35: 716-721.
7. Sanyal AJ, Banas C, Sargeant C, Luketic VA, Sterling RK, Stravitz RT, et al., Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C. Hepatology 2006; 43: 682-689.
8. D'Amico G, Garcia-Tsao G, Pagliaro L,. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006; 44: 217-231.
9. Merkel C, Bolognesi M, Angeli P, Noventa F, Caregaro L, Sacerdoti D, Gatta A,. Prognostic indicators of survival in patients with cirrhosis and esophageal varices, without previous bleeding. Am J Gastroenterol 1989; 84: 717-722.
10. Ginés P, Quintero E, Arroyo V, Terés J, Bruguera M, Rimola A, et al., Compensated cirrhosis: natural history and prognostic factors. Hepatology 1987; 7: 122-128.
11. Brandman D, Biggins SW, Hameed B, Roberts JP, Terrault NA,. Pretransplant severe hepatic encephalopathy, peritransplant sodium and post-liver transplantation morbidity and mortality. Liver Int 2012; 32: 158-164.
12. Allampati S, Mullen KD,. Does overt hepatic encephalopathy cause persistent cognitive defects even after successful liver transplantation? Liver Transpl 2014; 20: 874-875.
13. Sotil EU, Gottstein J, Ayala E, Randolph C, Blei AT,. Impact of preoperative overt hepatic encephalopathy on neurocognitive function after liver transplantation. Liver Transpl 2009; 15: 184-192.
14. Senzolo M, Pizzolato G, Ferronato C, Chierichetti F, Boccagni P, Dam M, Burra P,. Long-term evaluation of cognitive function and cerebral metabolism in liver transplanted patients. Transplant Proc 2009; 41: 1295-1296.
15. Dhar R, Young GB, Marotta P,. Perioperative neurological complications after liver transplantation are best predicted by pre-transplant hepatic encephalopathy. Neurocrit Care 2008; 8: 253-258.
16. Saner F, Gu Y, Minouchehr S, Ilker K, Fruhauf NR, Paul A, et al., Neurological complications after cadaveric and living donor liver transplantation. J Neurol 2006; 253: 612-617.
17. Tarter RE, Switala J, Plail J, Havrilla J, Van Thiel DH,. Severity of hepatic encephalopathy before liver transplantation is associated with quality of life after transplantation. Arch Intern Med 1992; 152: 2097-2101.
18. DiMartini A, Chopra K,. The importance of hepatic encephalopathy: pre-transplant and post-transplant. Liver Transpl 2009; 15: 121-123.
19. Sonny A, Kelly D, Hammel JP, Albeldawi M, Zein N, Cywinski JB,. Predictors of poor outcome among older liver transplant recipients. Clin Transplant 2015; 29: 197-203.
20. Yang X, Lu Q, Tang T, Liao R, Yang Z,. Prediction of the prognosis after liver transplantation in severe hepatitis B-induced liver failure and clinical decision for liver transplantation. J Surg Res 2013; 183: 846-851.
21. Patidar KR, Thacker LR, Wade JB, Sterling RK, Sanyal AJ, Siddiqui MS, et al., Covert hepatic encephalopathy is independently associated with poor survival and increased risk of hospitalization. Am J Gastroenterol 2014; 109: 1757-1763.
22. Shawcross DL, Sharifi Y, Canavan JB, Yeoman AD, Abeles RD, Taylor NJ, et al., Infection and systemic inflammation, not ammonia, are associated with Grade 3/4 hepatic encephalopathy, but not mortality in cirrhosis. J Hepatol 2011; 54: 640-649.
23. Esfeh JM, Hanouneh IA, Koval CE, Kovacs C, Dalal DS, Ansari-Gilani K, et al., Impact of pretransplant rifaximin therapy on early post-liver transplant infections. Liver Transpl 2014; 20: 544-551.
24. Cordoba J, Ventura-Cots M, Simõn-Talero M, Amorõs À, Pavesi M, Vilstrup H, et al., Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF). J Hepatol 2014; 60: 275-281.
25. Sun HY, Wagener M, Cacciarelli TV, Singh N,. Impact of rifaximin use for hepatic encephalopathy on the risk of early post-transplant infections in liver transplant recipients. Clin Transplant 2012; 26: 849-852.
26. Jalan R, Fernandez J, Wiest R, Schnabl B, Moreau R, Angeli P, et al., Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013. J Hepatol 2014; 60: 1310-1324.
27. Wang QM, Ji Q, Duan ZJ, Zhang M, Chang QY,. A study on the position and etiology of infection in cirrhotic patients: A potential precipitating factor contributing to hepatic encephalopathy. Exp Ther Med 2013; 6: 584-590.
28. Hung TH, Lay CJ, Chang CM, Tsai JJ, Tsai CC, Tsai CC,. The effect of infections on the mortality of cirrhotic patients with hepatic encephalopathy. Epidemiol Infect 2013; 141: 2671-2678.